ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Icariside II sensitizes osteosarcoma to doxorubicin through the lincROR/Wnt/β-catenin signaling regulatory axis.

Shu-Ting Zhou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.